The data bottleneck in digital health AI is the scarcity of high-frequency, longitudinal patient streams from wearables and Continuous Glucose Monitors (CGMs). Real data is siloed, privacy-restricted, and lacks the volume and pathological diversity needed to train robust algorithms. Automating the generation of synthetic streams eliminates this R&D blockade, enabling teams to simulate millions of patient-days with controlled events like nocturnal hypoglycemia or arrhythmic episodes. The operational upside is a 6-12 month acceleration in algorithm development and validation cycles, directly reducing time-to-market for monitoring and diagnostic products.




